MMP14 and gastric cancer: Kasurinen et al. assessed that patients with elevated serum MMP-14 levels had a 5-year disease-specific survival of 22.1%, while GC patients with lower concentrations of MMP-14 had a 5-year specific survival of 49.2%, and this difference was statistically significant (p = 0.01) [25].